All the latest (ASX:ALC) share price movements, news, expert commentary and investing advice from The Motley Fool Australia.

Which category is the right investment choice for you? Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative ...

Discusses Developments in Diabetes With Emphasis on Icovamenib and Clinical Trial Insights May 5, 2026 2:30 PM ...

Appointment supports revenue quality and profitability momentum as the Company activates its transformed operating base - Company announces further operational progress in its Comprehensive Transforma ...

DUBLIN, May 01, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (NASDAQ: TRIB) (“Trinity” or the “Company”), a commercial‑stage diagnostics and health technology company, today announced the appointment ...

Senseonics SENS recently announced the European launch of its groundbreaking Eversense 365 CGM system, the world’s first continuous glucose monitoring (CGM) system designed to last an entire year.

The next-generation CGM is now available in Sweden, with launches expected in Germany, Spain and Italy during the coming weeks as part of a ...

EmblemHealth, one of the nation’s largest not-for-profit health plans, today announced the citywide expansion of its Community Diabetes Wellness Program. Originally launched in the Bronx, the program ...

For those with type 2 diabetes (T2D), testing A1C levels has long been considered the gold standard of diabetes management. But it only measures the symptoms of type 2 diabetes. Weight loss, on the ...

For those with type 2 diabetes (T2D), testing A1C levels has long been considered the gold standard of diabetes management. But it only measures the symptoms of type 2 diabetes. Weight loss, on the ...